John Vavricka

Executive

US·SEC (Form 4)

Atea Pharmaceuticals, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 03 Feb 2026 for Atea Pharmaceuticals, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

John Vavricka: trading record in brief

John Vavricka discloses dealings in Atea Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 31 January 2024 to 31 January 2026, the count stands at 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 3 February 2026, reports an option exercise in Atea Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.